Close Menu

NEW YORK (GenomeWeb) – SpeeDx said today that it has entered a test development collaboration with British drugmaker GlaxoSmithKline.

According to Sydney-based SpeeDx, it will provide GSK with a combination of existing and custom-developed molecular diagnostic tests to support its antibiotic clinical trials, as well as its new product development efforts.

Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
19
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.